PRACTICE EVOLUTION: Decentralized Computer-Assisted IHC Image Analysis Liron Pantanowitz, MD, FCAP Director of Pathology Informatics Richard C. Friedberg,

Slides:



Advertisements
Similar presentations
Quantitative Assessment of Tissue-based IHC Biomarkers
Advertisements

Image analysis In our test case we assessed ER in TMAs that have been created using tissue samples from a large epidemiological study (UK Anglian Breast.
Regulation of Consumer Tests in California AAAS Meeting June 1-2, 2009 Beatrice OKeefe Acting Chief, Laboratory Field Services California Department of.
International Telecommunication Union Workshop on Standardization in E-health Geneva, May 2003 Digital Imaging in Pathology for Standardization Yukako.
Whole Slide Digital Images in Residency Education: Sliced Bread or Iced Dread? Lewis A. Hassell, MD University of Oklahoma Health Sciences Center Pathology.
Synopsis of FDA Colorectal Cancer Endpoints Workshop Michael J. O’Connell, MD Director, Allegheny Cancer Center Associate Chairman, NSABP Pittsburgh, PA.
Clinical Trial Designs for the Evaluation of Prognostic & Predictive Classifiers Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer.
Digital Pathology for Improved Patient Care
ACIS ® III Image Analysis Robert Carlson Manager, Imaging Systems *Accurate *Efficient *Consistent *Easy to use.
AIIA Lab, Department of Informatics Aristotle University of Thessaloniki Z.Theodosiou, F.Raimondo, M.E.Garefalaki, G.Karayannopoulou, K.Lyroudia, I.Pitas,
Computational Biology: A Measurement Perspective Alden Dima Information Technology Laboratory
Biomarkers on tumor tissue: from research to diagnostic tools used in the Clinic Bernard Têtu MD Professor of Pathology Laval University.
Dr Samah Kotb Lecturer of Biochemistry 1 CLS 432 Dr. Samah Kotb Nasr El-deen Biochemistry Clinical practice CLS 432 Dr. Samah Kotb Nasr.
Connecting Pathology into The Healthcare Ecosystem.
Concept of Measurement
Introduction of Cancer Molecular Epidemiology Zuo-Feng Zhang, MD, PhD University of California Los Angeles.
Magee-Womens Hospital of UPMC
Procedures used by CHTN
1 Historical overview of FDA regulation of digital pathology imaging applications: the safety and effectiveness issues Tremel A. Faison, MS, RAC, SCT(ASCP)
Predictors of HER2 FISH amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis Maria Vittoria Dieci 1,
Quality Assurance in the clinical laboratory
Round-Robin Review of HER2 Testing in the Context of Adjuvant Therapy for Breast Cancer (NCCTG N9831/BCIRG006/BCIRG005) 1 Concordance of HER2 Central Assessment.
Quantitative Image Analysis of HER2 Immunohistochemistry Compared with Manual Pathologist Analysis in Breast Cancer A Pilot Study Keith J.Kaplan, MD Geoffrey.
Moving Toward Personalized Treatment for Gastric Cancer: Role of HER2 Testing Frédérique Penault-Llorca, MD, PhD Professor of Pathology Centre Jean Perrin.
Diagnostic Assays to Plan Specific Drug Treatment Elizabeth Hammond MD.
HIV Testing Quality Assurance and Quality Control
High Volume Slide Scanning Architecture and Applications
High Performance Computing for Tissue MicroArray Analysis Dr Yinhai Wang David McCleary, Ching-Wei Wang, Jackie James, Dean Fennell, Peter Hamilton.
FDA Panel Digital Pathology Oct 22/23 Dirk Soenksen, President.
FOR RESEARCH USE ONLY CONFIDENTIAL Page 1 Enabling Digital Pathology Enabling Digital Pathology September 2007.
Development of CAP Standards for Digital Pathology That Would be Important for CAP Accreditation of Pathology Labs as We Transition Into a Digital Era.
The 70 gene Mammaprint ™ signature: a comparison with traditional clinico-pathological parameters. Patrizia Querzoli 1, Massimo Pedriali 1, Gardenia Munerato.
Cap.org v. FNL FDA: Challenges to Protecting Public Health – Pathology’s Perspective Roger D. Klein, M.D., JD, F.C.A.P. March 7, 2013 Advocacy.
Single Cell Tomography for Early Cancer Detection Vivek Nandakumar, Laimonas Kelbauskas, Roger Johnson, Deirdre Meldrum Arizona State University, Tempe,
European Cooperation in the field of Scientific and Technical Research COST is supported by the EU RTD Framework Programme ESF provides.
1 Preclinical-Bench Testing II Using Human Observers to Objectively Measure and Evaluate Imaging Performance of Digital WSI Systems Max Robinowitz, MD.
Implementing universal Lynch Syndrome screening in a large healthcare system.
Sgroi DC et al. Proc SABCS 2012;Abstract S1-9.
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
The Results of Automated Image Analysis Workshop at the 10th European Congress on Telepathology and 4th International Congress on Virtual Microscopy Arvydas.
Challenges of Cancer Diagnosis in Resource Limited Settings Optimizing Pathology Support Ann Marie Nelson, M.D. AIDS and Infectious Disease Pathology Joint.
An International Ki67 Reproducibility Study Nielsen TO et al. Proc SABCS 2012;Abstract S4-6.
The Use of Predictive Biomarkers in Clinical Trial Design Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute
© Fraunhofer MEVIS Meeting of the Working Group VCBM, 3. September 2013, Vienna Frank Heckel Fraunhofer MEVIS, Bremen, Germany | Innovation Center Computer.
Prognostic and Predictive Factors: Current Evidence for Individualized Therapy Predictive Molecular Markers: Hormone Receptor Status Presented by Kathleen.
Biochemistry Clinical practice CLS 432 Dr. Samah Kotb Lecturer of Biochemistry 2015 Introduction to Quality Control.
Evaluating the New Technologies Ann Sefton Faculties of Medicine and Dentistry University of Sydney.
Digital Imaging in Education and Distributed Pathology Practice
Issues in Validation of Whole Slide Digital Images for Frozen Section Interpretation Lewis A. Hassell, MD Pathology Visions October 2010.
W. Scott Campbell, Ph.D., MBA University of Nebraska Medical Center
 Routine viral diagnostics: indirect and direct detection of viruses. ◦ Indirect detection: serological tests; ◦ Direct detection:  Viral antigens;
From Qualitative to Quality Impact Heather Bryant, MD, PhD Health System Use Summit February, 2016.
12 th European Congress on Digital Pathology previously European Congress on Telepathology and international Congress on Virtual Microscopy College des.
Digital Pathology, An Introduction From glass slides to digital files and there after.
Introduction to Quality Assurance. Quality assurance vs. Quality control.
High-throughput genomic profiling of tumor-infiltrating leukocytes
Introduction to INDONESIA Ring QUALITY ASSESSMENT (RQA)
Validation and Interpretation in Cellular Pathology
Laboratory Information Management Systems (LIMS)
Patient Biospecimen Preanalytics:
Immunoscore Prognostic in Colon Cancer
The Immunoscore in Colon Cancer (CC): Comparison of the digital workflow to conventional histology for the quantification of CD3 and CD8 positive and tumor-infiltrating.
Pathology Spatial Analysis February 2017
In Search of the Optimal Set of Indicators when Classifying Histopathological Images Catalin Stoean University of Craiova, Romania
FDA Panel Digital Pathology Oct 22/23
CLASSIFICATION OF TUMOR HISTOPATHOLOGY VIA SPARSE FEATURE LEARNING Nandita M. Nayak1, Hang Chang1, Alexander Borowsky2, Paul Spellman3 and Bahram Parvin1.
Tremel A. Faison, MS, RAC, SCT(ASCP) FDA/CDRH/OIVD/DIHD
WSI-FS II: Validation of Squamous Cell Carcinoma Frozen Section Whole Slide Image Diagnosis in Surgical Pathology Vamsi Parimi MD1; Ryba Dominika, Ewa.
Tremel A. Faison, MS, RAC, SCT(ASCP) FDA/CDRH/OIVD/DIHD
Quality Control Lecture 3
Presentation transcript:

PRACTICE EVOLUTION: Decentralized Computer-Assisted IHC Image Analysis Liron Pantanowitz, MD, FCAP Director of Pathology Informatics Richard C. Friedberg, MD PhD, FCAP Chairman, Department of Pathology Baystate Health, Springfield, MA Tufts University School of Medicine

Why Are We Doing This? Practice BackgroundPractice Background Today’s EnvironmentToday’s Environment Increased technological innovation Increased technological innovation Increased biological information Increased biological information Increased clinical demand Increased clinical demand Convergence of two independent long term trendsConvergence of two independent long term trends

Key Trend #1 in the Practice of Anatomic Pathology Evolution along Clinical Pathology linesEvolution along Clinical Pathology lines Greater concern with analytical precision, reproducibility, accuracy, specificity, reliability Greater concern with analytical precision, reproducibility, accuracy, specificity, reliability Qualitative becoming quantitative Qualitative becoming quantitative “Stains” becoming “assays” “Stains” becoming “assays” Results directly tied to treatment, not just prognosis Results directly tied to treatment, not just prognosis Diminishing “guild” mentality with anointed experts Diminishing “guild” mentality with anointed experts ExamplesExamples IHC & ELISA IHC & ELISA Her2/neu & Herceptin Her2/neu & Herceptin

Key Trend #2 in the Practice of Anatomic Pathology Evolution along Radiology/Imaging linesEvolution along Radiology/Imaging lines Analog images establish the field Analog images establish the field Market & technology forces start trend to digital imaging Market & technology forces start trend to digital imaging Initially, scanning of analog imagesInitially, scanning of analog images Later, digitally acquired imagesLater, digitally acquired images Digitalization of images allows new applications Digitalization of images allows new applications Significant workload & throughput implications Significant workload & throughput implications ExamplesExamples PACS PACS Convergence imaging Convergence imaging Windowing Windowing Dynamic images Dynamic images Telediagnostics Telediagnostics

Expectations EventuallyEventually Every “image-based” pathologist will use computer-assisted analytic tools to assay specimens Every “image-based” pathologist will use computer-assisted analytic tools to assay specimens Intelligently designed PACS will revolutionize pathology workflow Intelligently designed PACS will revolutionize pathology workflow Increased reliance upon pathology Increased reliance upon pathology

Breast Cancer & Immunohistochemistry (IHC) Determining breast tumor markers (ER, PR & HER-2/neu) for prognostic & predictive purposes by IHC &/or FISH is the standard of practice. Determining breast tumor markers (ER, PR & HER-2/neu) for prognostic & predictive purposes by IHC &/or FISH is the standard of practice. IHC score/quantification by manual microscopy is currently accepted as the traditional gold standard. IHC score/quantification by manual microscopy is currently accepted as the traditional gold standard. Surgical Pathology workflow involves: Surgical Pathology workflow involves: Pre-analytic preparation (e.g. tissue fixation & processing)Pre-analytic preparation (e.g. tissue fixation & processing) Analysis (i.e. staining of controls & patient slides)Analysis (i.e. staining of controls & patient slides) Post-analytical component (e.g. quantification & reporting)Post-analytical component (e.g. quantification & reporting) Discrepancies between HER2 IHC & FISH mainly reflect errors in manual interpretation & not reagent limitations (Bloom & Harrington. AJCP 2004; 121:620-30). Discrepancies between HER2 IHC & FISH mainly reflect errors in manual interpretation & not reagent limitations (Bloom & Harrington. AJCP 2004; 121:620-30). Inter- & intra-observer differences in scoring occur: Inter- & intra-observer differences in scoring occur: Most notably with borderline & weakly stained casesMost notably with borderline & weakly stained cases Related to fatigue & subjectivity of human observersRelated to fatigue & subjectivity of human observers

Accuracy is Required Accuracy = the amount by which a measured value adheres to a standard. Accuracy = the amount by which a measured value adheres to a standard. The need for precise ER, PR & HER2/neu status in breast cancer is required to ensure appropriate therapeutic intervention. The need for precise ER, PR & HER2/neu status in breast cancer is required to ensure appropriate therapeutic intervention. Lay press have communicated concerns over inaccuracies in breast biomarker testing. Lay press have communicated concerns over inaccuracies in breast biomarker testing. Threat of having to refer such testing to reference laboratories. Threat of having to refer such testing to reference laboratories. Is computer assisted image analysis (CAIA) a better (i.e. more accurate & reproducible) method for scoring IHC? Is computer assisted image analysis (CAIA) a better (i.e. more accurate & reproducible) method for scoring IHC?

Guidelines ASCO/CAP Guideline Recommendations for HER2/neu testing in breast cancer (Wolff et al. Arch Pathol Lab Med 2007; 131:18) ASCO/CAP Guideline Recommendations for HER2/neu testing in breast cancer (Wolff et al. Arch Pathol Lab Med 2007; 131:18) Image analysis can be an effective tool for achieving consistent interpretationImage analysis can be an effective tool for achieving consistent interpretation A pathologist must confirm the image analysis resultA pathologist must confirm the image analysis result Image analysis equipment (including optical microscopes) must be calibrated, subjected to regular maintenance & internal QC evaluationImage analysis equipment (including optical microscopes) must be calibrated, subjected to regular maintenance & internal QC evaluation Image analysis procedures must be validatedImage analysis procedures must be validated Canadian National Consensus Meeting on HER2/neu testing in breast cancer (Hanna et al. Current Oncology 2007; 14:149-53) Canadian National Consensus Meeting on HER2/neu testing in breast cancer (Hanna et al. Current Oncology 2007; 14:149-53) Use of image analysis systems can be useful to enhance reproducibility of scoringUse of image analysis systems can be useful to enhance reproducibility of scoring Pathologists must supervise all image analysesPathologists must supervise all image analyses FDA clearance for CAIA in vitro diagnostic use of HER-2/neu, ER, and PR IHC has been obtained by several companies FDA clearance for CAIA in vitro diagnostic use of HER-2/neu, ER, and PR IHC has been obtained by several companies

CAIA vs. Manual Score Remmele & Schicketanz. Pathol Res Pract 1993; 189:862-6 “Subjective grading of slides is a simple, rapid and useful method for the determination of tissue receptor content and must not be replaced by expensive and time-consuming computer-assisted image analysis in daily practice.” “Subjective grading of slides is a simple, rapid and useful method for the determination of tissue receptor content and must not be replaced by expensive and time-consuming computer-assisted image analysis in daily practice.”

Data on CAIA & IHC Early studies showed CAIA was no better than visual analysis Early studies showed CAIA was no better than visual analysis (Schultz et al. Anal Quant Cytol Histol 1992; 14:35-40 ) Few studies have shown that manual & CAIA are comparable Few studies have shown that manual & CAIA are comparable (Diaz et al. Ann Diagn Pathol 2004; 8:23-7) Most studies found CAIA to be superior to manual methods Most studies found CAIA to be superior to manual methods (Taylor & Levenson. Histopathology 2006; 49::411-24; McClelland et al. Cancer Res 1990; 50: ; Kohlberger et al. Anticancer Res 1999; 19: ; Wang et al. Am J Clin Pathol 2001; 116: ; Turner et al. USCAP 2008 abstract 1694). Provides effective qualitative & quantitative evaluationProvides effective qualitative & quantitative evaluation More consistent than manual & digital microscopyMore consistent than manual & digital microscopy More precise (scan per scan) than pathologistsMore precise (scan per scan) than pathologists One study showed agreement between different CAIA systems: Chroma Vision ACIS & Applied Imaging Ariol SL-50 One study showed agreement between different CAIA systems: Chroma Vision ACIS & Applied Imaging Ariol SL-50 (Gokhale et al. Appl Immunohistochem Mol Morphol 2007; 15:451-5)

Published Considerations Expense of CAIA may be hard to justify where volumes are low Expense of CAIA may be hard to justify where volumes are low Image analysis frequently requires interactive input by the pathologist Image analysis frequently requires interactive input by the pathologist Increased time requirements Increased time requirements Systems may be discrepant when tumor cells have low levels of staining Systems may be discrepant when tumor cells have low levels of staining Interfering non-specific staining within selected areas Interfering non-specific staining within selected areas Images must be free from artifacts Images must be free from artifacts Small amounts of stained tissue can erroneously generate lower scores Small amounts of stained tissue can erroneously generate lower scores

CAIA Systems ImageJ (NIH developed freeware)ImageJ (NIH developed freeware) Adobe Photoshop softwareAdobe Photoshop software (Lehr et al J Histochem Cytochem 1997; 45: ) Automated Cellular Imaging System (Chroma Vision)Automated Cellular Imaging System (Chroma Vision) Pathiam (BioImagene)Pathiam (BioImagene) Applied Imaging Ariol (Gentix Systems)Applied Imaging Ariol (Gentix Systems) Spectrum (Aperio)Spectrum (Aperio)

Image Analysis & Algorithms Object-Oriented Image Analysis (morphology- based) Object-Oriented Image Analysis (morphology- based) Involves color normalization, background extraction, segmentation, classification & feature selection Involves color normalization, background extraction, segmentation, classification & feature selection Separation of tissue elements (e.g. tumor epithelium) from background (e.g. stroma) permits selection of areas of interest & filtering out of unwanted areas Separation of tissue elements (e.g. tumor epithelium) from background (e.g. stroma) permits selection of areas of interest & filtering out of unwanted areas Region of Interest (ROI) is subject to further image analysis (computation of diagnostic score) Region of Interest (ROI) is subject to further image analysis (computation of diagnostic score) Quantification of results Quantification of results

Digital Algorithm Courtesy of BioImagene

Validation & Implementation at Baystate Health Distant medical centers Distant medical centers Significant breast IHC caseload Significant breast IHC caseload Need to mimic daily practice Need to mimic daily practice avoid central (single user) image analysisavoid central (single user) image analysis Bandwidth limitations Bandwidth limitations Whole slide imager availability Whole slide imager availability Professional reluctance to read digital images Professional reluctance to read digital images

Key Components Multimedia PC upgrade Multimedia PC upgrade Spot Diagnostic digital cameras for each workstation Spot Diagnostic digital cameras for each workstation Pathiam (BioImagene) web-based application Pathiam (BioImagene) web-based application Server (Oracle database + application + image file storage) Server (Oracle database + application + image file storage) Training & Validation Training & Validation

WORKFLOW CONTROL IHC PATIENT IHC FOV ANALYSIS REPORT GENERATION

NEED FOR STANDARDIZATION

Calibrated Workstations

FOV IHC Analysis FFPE breast cases routinely stained for ER, PR & HER2-neu FFPE breast cases routinely stained for ER, PR & HER2-neu Standardized camera acquisition settings (calibration) Standardized camera acquisition settings (calibration) Pathologists (n=3) acquired 3-5 FOVs (each at 20x Mag.) Pathologists (n=3) acquired 3-5 FOVs (each at 20x Mag.) Uniform jpg image file formats used (4 Mb) Uniform jpg image file formats used (4 Mb) Post-processing image manipulation was avoided Post-processing image manipulation was avoided Control parameter set defined/IHC run (default/modified) Control parameter set defined/IHC run (default/modified) ER/PR nuclear staining analyzed using the Allred scoring system (i.e. proportion + intensity score = TS) ER/PR nuclear staining analyzed using the Allred scoring system (i.e. proportion + intensity score = TS) HER-2/neu membranous staining evaluated per ASCO/CAP 2007 recommendations (0, 1+, 2+, 3+) HER-2/neu membranous staining evaluated per ASCO/CAP 2007 recommendations (0, 1+, 2+, 3+) Manual vs. CAIA comparison tracked (IHC score, time & problems) Manual vs. CAIA comparison tracked (IHC score, time & problems) FISH for HER2/neu obtained on several cases FISH for HER2/neu obtained on several cases

ER/PR Correlation (N=29) Bio- marker ConcordantCases Discordant Cases ER+160 ER - 42* PR+140 PR - 43* * 3 cases

HER-2/Neu Results (N=28) Score0/ /1+161* 2+31** 3+4 CAIA Manual Scoring FISH RESULTS: * Negative (Ratio 1.04) ** Abnormal (Ratio 6.5)

HER-2/Neu FISH Correlation Manual Score CAIA Score FISH Result 00 Negative (1.06) 00 Negative (0.93) 11 Negative (1.04) 10 Negative (1.00) 10 Negative (1.07) 10 Negative (1.66) 21 Negative (1.04) 32 Abnormal (6.5)

Challenging Cases Infiltrating Lobular Carcinoma Cytoplasmic Staining Infiltrating Lobular Carcinoma Cytoplasmic Staining

Lessons Learned Decentralized CAIA for IHC designed to mimic daily surgical pathology workflow in practice is feasible Decentralized CAIA for IHC designed to mimic daily surgical pathology workflow in practice is feasible Image acquisition requires standardization Image acquisition requires standardization Tissue heterogeneity may impact FOV selection (whether biological or due to IHC variation) Tissue heterogeneity may impact FOV selection (whether biological or due to IHC variation) Pathologists must supervise CAIA systems Pathologists must supervise CAIA systems

Future Prospects Adopt virtual workflow-centric systems feasible for routine practice (that may potentially show better results) Adopt virtual workflow-centric systems feasible for routine practice (that may potentially show better results) E.g. Whole slide imaging (WSI) to eliminate the need to standardize different systemsE.g. Whole slide imaging (WSI) to eliminate the need to standardize different systems Automatic ROI selection & image analysis Automatic ROI selection & image analysis Shortened analysis time Shortened analysis time AP-LIS & CAIA system integration AP-LIS & CAIA system integration To improve workflowTo improve workflow Permit disparate systems to access the same digital images & case dataPermit disparate systems to access the same digital images & case data Learning algorithms Learning algorithms Systems that improve with experience following pathologist feedbackSystems that improve with experience following pathologist feedback Clinical outcome studies are needed Clinical outcome studies are needed In one study, CAIA for ER IHC yielded results that did not differ from human scoring against patient outcome gold standards (Turbin et al. Breast Cancer Res Treat 2007)In one study, CAIA for ER IHC yielded results that did not differ from human scoring against patient outcome gold standards (Turbin et al. Breast Cancer Res Treat 2007)

Acknowledgements Christopher N. Otis, MD Giovana M. Crisi, MD Andrew Ellithorpe, MHS Peter Marquis, BA BioImagene

TRANSFORMING PATHOLOGY: Emerging technology driving practice innovation